Democratic Republic of Congo faces Ebola outbreak

On 17 May 2026, the World Health Organization (WHO) declared the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern (PHEIC), marking the latest chapter in the Central African nation’s long battle with Ebola virus disease. The declaration followed confirmation of a new epidemic in Ituri province, accompanied by cases in neighbouring Uganda, which raised alarms about cross‑border spread and the possibility of a wider regional crisis.

NATURE AND SCALE OF THE OUTBREAK

The epidemic, which emerged in the eastern province of Ituri, is caused by the Bundibugyo ebolavirus, a less common strain compared to the Zaire ebolavirus that has driven most previous DRC outbreaks. Early WHO tallies showed at least eight laboratory‑confirmed cases, more than 240 suspected cases, and around 80 deaths in the DRC, with over 300 suspected infections and nearly 90 fatalities reported shortly after the PHEIC announcement. A small number of confirmed cases were also detected in Kampala, Uganda, underscoring the outbreak’s potential to move beyond a localized rural crisis into urban and regional centres.

The Bundibugyo strain is particularly concerning because existing Ebola vaccines and specific treatments are largely tailored to the Zaire virus, leaving public‑health teams with fewer tried‑and‑tested tools to contain transmission. This complicates contact‑tracing, isolation, and post‑exposure prophylaxis strategies, increasing the risk of chains of transmission that are harder to break. Furthermore, the initial data suggest that a large proportion of cases are among adults aged 20–39, with women over‑represented, pointing to intense household and caregiving‑related transmission.

WHY THE PHEIC WAS DECLARED

The WHO convened an emergency committee under the International Health Regulations (IHR) and determined that the outbreak met the criteria for a PHEIC because it represented an “extraordinary” public‑health risk with the potential for international spread. The combination of rising case numbers, cross‑border transmission into Uganda, and significant uncertainty about the true geographic spread justified the high‑level alert. The WHO emphasised that the situation did not yet constitute a pandemic, but rather a regional emergency requiring coordinated international support.

The PHEIC status is not merely symbolic; it triggers increased international funding, technical assistance, and coordination, and can prompt countries to adjust travel and trade measures in line with public‑health guidance rather than arbitrary border closures. For the DRC, it meant that WHO, Africa CDC, and partner agencies would intensify deployments of rapid‑response teams, diagnostic capacity, and risk‑communication support, while encouraging donor countries and foundations to mobilise additional resources.

CHALLENGES TO THE RESPONSE

The response in Ituri faces several overlapping challenges. The province is remote, forested, and poorly served by roads and health infrastructure, which complicates the movement of medical teams, ambulances, and supplies. At the same time, parts of eastern DRC remain affected by ongoing insecurity and armed conflict, which can disrupt surveillance, contact tracing, and community engagement efforts. Local residents may also be wary of health workers because of previous experiences with Ebola‑related lockdowns, militarised quarantines, or misinformation, making it harder to gain trust and secure cooperation.

The lack of licensed vaccines or proven therapeutics specifically for Bundibugyo adds another layer of difficulty. While general Ebola control measures – rapid case identification, isolation, safe burials, contact tracing, and community mobilisation – remain effective, the absence of a strain‑specific vaccine means that protection for frontline workers and high‑risk contacts is more limited. This has prompted calls for accelerated research into candidate vaccines and antivirals that could cover multiple Ebola species, as well as for expanded use of experimental treatments under ethical oversight.

REGIONAL AND GLOBAL IMPLICATIONS

The spillover of confirmed cases into Uganda underscores how porous borders and routine cross‑border movement can accelerate the geographic reach of Ebola. Uganda has previous experience with Ebola outbreaks and has relatively strong surveillance systems, but even so, any new cluster in a densely populated city such as Kampala raises fears of explosive urban transmission if containment lapses. Regional bodies such as the Africa CDC and the East African Community are thus focusing on harmonising screening at borders, sharing laboratory capacity, and coordinating cross‑border contact‑tracing.

Globally, the 2026 PHEIC serves as a reminder that although Ebola remains geographically concentrated in Central and West Africa, the virus can quickly become a transnational concern. The declaration may also influence how countries approach travel advisories and health screening for passengers arriving from affected regions, while reinforcing the need for sustained investment in health‑system resilience and outbreak‑preparedness in low‑ and middle‑income countries.